Stempeutics research gets DCGI nod for stem cell based product

The company's goal is to globalise Stempeucel for Buerger's Disease and the market size is approximately $ 1.5 billion worldwide.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news